MXETX
Price
$14.52
Change
-$0.11 (-0.75%)
Updated
Jul 13 closing price
Net Assets
817.37M
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

MXETX vs VSMPX

MXETX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
MXETX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXETX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. MXETX (817M). VSMPX pays higher dividends than MXETX: VSMPX (1.06) vs MXETX (0.83). MXETX was incepted earlier than VSMPX: MXETX (6 years) vs VSMPX (11 years). MXETX (0.91) is less costly to investors than VSMPX (0.02). MXETX is a more actively managed with annual turnover of: 28.00 vs. VSMPX (3.00). MXETX has a lower initial minimum investment than VSMPX: MXETX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. MXETX (15.34). VSMPX return over 5 years is better than : 66.52 vs. MXETX (28.05).
MXETXVSMPXMXETX / VSMPX
Total Expense Ratio0.900.024,500%
Annual Report Gross Expense Ratio0.910.024,550%
Fund Existence6 years11 years-
Gain YTD12.32111.206110%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets817M2.3T0%
Annual Yield % from dividends0.831.0678%
Returns for 1 year15.3421.4871%
Returns for 3 years44.6567.0367%
Returns for 5 years28.0566.5242%
Returns for 10 yearsN/A239.43-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C